Showing results 1 to 1 of 1
| Title | Author(s) | Issue Date | |
|---|---|---|---|
A Phase III randomized double-blind placebo-controlled study to evaluate the efficacy and safety of abatacept or placebo on standard of care in patients with active Class III or IV lupus nephritis Proceeding/Conference:The 39th Korean College of Rheumatology Annual Scientific Meeting & the 13th International Symposium, 2019 | 2019 |